Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Laurence A. Rubin, Carole C. Kurman, M E Fritz et al. · The Journal of Immunology · 1985 · 1.2K citations · Full text

Life Sciences, Immunology, Cellular Immunology +12

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

Bruce Beutler, David A. Greenwald, J D Hulmes et al. · Nature · 1985 · 1.1K citations

Life Sciences, Cell Biology, Immunology +14

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Kimberly J. Van Zee, Tadahiko Kohno, E Fischer et al. · Proceedings of the National Academy of Sciences · 1992 · 852 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +15

General rules for clinical and pathological studies on cancer of the colon, rectum and anus

Dennosuke Jinnai · Surgery Today · 1983 · 635 citations

Medicine, Oncology, Pathology +14

Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.

Hartmut Engelmann, Daniela Novick, David Wallach · Journal of Biological Chemistry · 1990 · 553 citations · Full text

Life Sciences, Biochemistry, Immunology +9